SUZHOU,China,May 23,2024-- On May 10,2024,Cure Genetics announced the safety and efficacy data of their CAR-NKT product,CGC729,for patients with relapsed and refractory metastatic renal cell carcinoma
HYDERABAD,India,May 24,2024-- Hyderabad,the City of Pearls in India,witnessed the unveiling of its newest crowning jewel – Megaleio,an opulent residential project designed to redefine luxury living.
SUZHOU,ChinaandROCKVILLE,Md.,May 24,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel therapies for cancer,chronic hepatitis B (CHB),and age-related dis
BEIJING,May 24,2024-- A news report from ifeng.com: Recently,the Alibaba Cloud International Summit,with the core theme of "Orange Cloud Going Global,New Journey of Financial Technology",was
Oral Presentation：a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer
The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.
